International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report) shares crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.09 and traded as high as $0.10. International Stem Cell shares last traded at $0.10, with a volume of 800 shares traded.
International Stem Cell Stock Performance
The stock has a market capitalization of $1.04 million, a PE ratio of -1.63 and a beta of 0.05. The stock’s 50 day moving average is $0.11 and its two-hundred day moving average is $0.09.
International Stem Cell Company Profile
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Recommended Stories
- Five stocks we like better than International Stem Cell
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- What to Know About Investing in Penny Stocks
- Alphabet’s Officially In A Bear Market—Time To Buy?
- How Can Investors Benefit From After-Hours Trading
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg&h=45&w=95&zc=2){kind=logo}
